Among the novel candidate causal genes to highlight, BTN3A2 showed a relatively large effect on ischemic stroke, and the significant result was consistent across different datasets and methods, suggesting a crosstalk between immune modulation and stroke pathogenesis. The gene discussed is BTN3A2; the disease is stroke disorder.